MODIFICATION, WARRANT AND INVESTOR RIGHTS AGREEMENTModification, Warrant and Investor Rights Agreement • April 17th, 2009 • Akorn Inc • Pharmaceutical preparations • New York
THIS MODIFICATION, WARRANT AND INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of April 13, 2009, by and among AKORN, INC., a Louisiana corporation (“Akorn”), AKORN (NEW JERSEY), INC., an Illinois corporation (“Akorn NJ”, and together with Akorn, collectively, the “Borrowers” and individually as a “Borrower”), and EJ FUNDS LP, a Delaware limited partnership, in its capacity as Agent (the “Agent”) for the lenders from time to time parties to the Credit Agreement (defined herein) (the “Lenders”), and the Lender party hereto (the “Lender”).
